Vaxcyte, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2019 to Q2 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Vaxcyte, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2019 to Q2 2024.
- Vaxcyte, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$129M, a 88.3% decline year-over-year.
- Vaxcyte, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$497M, a 87.8% decline year-over-year.
- Vaxcyte, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$402M, a 80% decline from 2022.
- Vaxcyte, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$223M, a 123% decline from 2021.
- Vaxcyte, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$100M, a 12.2% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)